Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR*ICU) Trial

NACompletedINTERVENTIONAL
Enrollment

30,000

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

August 31, 2006

Conditions
Bacterial Diseases
Interventions
PROCEDURE

Intensive Control Strategy

BEHAVIORAL

Standard Control Strategy

Trial Locations (19)

10003

Beth Israel Medical Center, New York

21201

University of Maryland Medical Center, Baltimore

30303

Emory University School of Medicine, Atlanta

32224

Mayo Clinic - Jacksonville, Jacksonville

33136

University of Miami, Miami

44106

University Hospitals of Cleveland, Cleveland

48109

University of Michigan, Ann Arbor

48201

Harper University Hospital, Detroit

52242

University of Iowa, Iowa City

55906

Mayo Clinic, Rochester

60637

University of Chicago, Chicago

85259

Mayo Clinic Arizona, Scottsdale

97239

Oregon Health Sciences University, Portland

35294-0006

University of Alabama at Birmingham, Birmingham

85724-5023

University of Arizona Health Sciences Center, Tucson

06510

Yale University, New Haven

02114

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

08103

Cooper University Hospital, Camden

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00100386 - Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR*ICU) Trial | Biotech Hunter | Biotech Hunter